These data suggest that GCN5L1 deletion suppressed the expression of iron release transporters to enhance iron accumulation, which could promote lipid peroxidation and make HCC cells be standby for sorafenib-induced ferroptosis. Here, BLOC1S1 is linked to hepatocellular carcinoma.